Skip to content
Home/Companies/MedTech/ZOMP
ZOMP

ZOMP

MedTech·United Kingdom·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns ZOMP?

ZOMP is a British MedTech company, currently owned by ZEISS Ventures since 2023.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
ZEISS Ventures
Investor
ZEISS Ventures
ZEISS Ventures CVC · 2019 · Evergreen

Key facts

HQUnited Kingdom
SectorMedTech
StatusActive
Websitewww.zomp.one

More from ZEISS Ventures CVC

Other portfolio companies in the same fund.

Custom Surgical
Custom Surgical
Active
MedTechGermany· 2026
Maculaser
Active
MedTechFinland· 2026
arcoris bio
Active
BiotechSwitzerland· 2025
Lidrotec
Active
Deep TechGermany· 2025
Odne
Active
MedTechSwitzerland· 2025
Surgify Medical
Active
MedTechFinland· 2025

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns ZOMP?

ZOMP is currently owned by ZEISS Ventures, through ZEISS Ventures CVC, since 2023.

When did ZEISS Ventures acquire ZOMP?

ZEISS Ventures acquired ZOMP in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue